Ezekowitz, M. D., & Brückmann, M. (2016). Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: The RE-LY trial (Randomized Evaluation of Long-Term Anticoagulant Therapy). Circulation, 134(8), . https://doi.org/10.1161/CIRCULATIONAHA.115.020950
Chicago Style (17th ed.) CitationEzekowitz, Michael D., and Martina Brückmann. "Comparison of Dabigatran and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy)." Circulation 134, no. 8 (2016). https://doi.org/10.1161/CIRCULATIONAHA.115.020950.
MLA (9th ed.) CitationEzekowitz, Michael D., and Martina Brückmann. "Comparison of Dabigatran and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy)." Circulation, vol. 134, no. 8, 2016, https://doi.org/10.1161/CIRCULATIONAHA.115.020950.